Cimzia (Certolizumab Pegol) News and Research

RSS
FDA approves treatment for adults with non-radiographic axial spondyloarthritis

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

UCB initiates EXXELERATE study in rheumatoid arthritis

UCB initiates EXXELERATE study in rheumatoid arthritis

UCB to present new data on Cimzia at ACG annual scientific meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

PDL, UCB enter definitive settlement agreement to resolve all legal patent disputes

PDL, UCB enter definitive settlement agreement to resolve all legal patent disputes

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

XOMA sells royalty interest in CIMZIA

XOMA sells royalty interest in CIMZIA

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data from efficacy study of CIMZIA in Crohn's disease patients presented

New data from efficacy study of CIMZIA in Crohn's disease patients presented

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

FDA forces manufacturers of TNF-blockers to highlight risk of fungal infections

FDA forces manufacturers of TNF-blockers to highlight risk of fungal infections

Arthritis drugs used in children to be investigated because of cancer link

Arthritis drugs used in children to be investigated because of cancer link

FDA approves Cimzia as treatment for Crohn's disease

FDA approves Cimzia as treatment for Crohn's disease

New drug shows promise in treating Crohn's disease

New drug shows promise in treating Crohn's disease

UCB submits application to FDA for new treatment in Crohn's disease

UCB submits application to FDA for new treatment in Crohn's disease